All Stories

  1. Plasma exchange following immunoglobulins for Guillain-Barré-Syndrome: a persisting problematic practice?
  2. HEAT STRESS AND NEUROLOGICAL BIOMARKERS IN OUTDOOR WORKERS: A CROSS-SECTIONAL OBSERVATIONAL STUDY
  3. Work Productivity Loss in People Living With Long COVID Symptoms: a good start and a missed opportunity
  4. European neurologists need to be aware of chikungunya (CHIKV) and dengue (DENV) viruses
  5. CT Perfusion Changes in Ischemic Stroke Due to Isolated Internal Carotid Artery Occlusions: From Severity Assessment to Therapy
  6. Occupational zoonoses, neurological diseases, and public health: A one health approach
  7. EBV and Molecular Mimicry: Therapeutic Implications
  8. Immune Response Against SARS-CoV-2
  9. Comparison of dry and wet electroencephalography for the assessment of cognitive evoked potentials and sensor-level connectivity
  10. Brain oscillatory processes related to sequence memory in healthy older adults
  11. Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection
  12. Brain oscillatory processes related to sequence memory in healthy older adults
  13. Intensive Social Interaction for Treatment of Poststroke Depression in Subacute Aphasia: The CONNECT Trial
  14. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19
  15. Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors
  16. Impact of COVID-19 emergency on the psychological well-being of susceptible individuals
  17. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection
  18. Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
  19. Publisher Correction: Epitopes for a 2019-nCoV vaccine
  20. An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines
  21. COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection
  22. Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry
  23. Increased Recruitment of Domain-General Neural Networks in Language Processing Following Intensive Language-Action Therapy: fMRI Evidence From People With Chronic Aphasia
  24. Cerebrospinal fluid findings in COVID-19 indicate autoimmunity
  25. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism
  26. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
  27. A Peptide Link Between Human Cytomegalovirus Infection, Neuronal Migration, and Psychosis
  28. Epitopes for a 2019-nCoV vaccine
  29. COVID-19 Outbreak in Lombardy, Italy: An Analysis of the Short-Term Role of Air Pollution and Meteorological Factors
  30. Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins
  31. Cross-Reactivity as a Mechanism Linking Infections to Stroke
  32. Cytomegalovirus Infection: The Neurodevelopmental Peptide Signatures
  33. Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders
  34. Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial
  35. The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond
  36. Communicative-Pragmatic Assessment Is Sensitive and Time-Effective in Measuring the Outcome of Aphasia Therapy
  37. From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link
  38. Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions
  39. A Spiking Neurocomputational Model of High-Frequency Oscillatory Brain Responses to Words and Pseudowords
  40. Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical and Meaningful/less Mini-Constructions
  41. Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia
  42. Minimal immune determinants connect Zika virus, human Cytomegalovirus, andToxoplasma gondiito microcephaly-related human proteins
  43. Reply concerning the article “Zika virus and autoimmunity: From microcephaly to Guillain–Barré syndrome, and beyond”
  44. Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond
  45. Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein
  46. Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
  47. H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment
  48. EBV-Associated Cancer and Autoimmunity: Searching for Therapies
  49. Single Amino Acid Repeats Connect Viruses to Neurodegeneration
  50. The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy
  51. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
  52. Predictors and dynamics of postpartum relapses in women with multiple sclerosis
  53. Peptide matching between Epstein-Barr virus and human proteins
  54. Peptide profiling of the route from Mahoney to Sabin, and return
  55. Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins
  56. Confronting JC virus and Homo sapiens biological signatures 
  57. West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses
  58. Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
  59. Increasing age at disability milestones among MS patients in the MSBase Registry
  60. Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome
  61. A peptide talk between JC virus and the human host: from silent infection to autoimmunity
  62. Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study
  63. Developing an anti-Campylobacter jejunivaccine
  64. Circumscribing the Conformational Peptide Epitope Landscape
  65. How a single amino acid change may alter the immunological information of a peptide
  66. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry
  67. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude
  68. Treating multiple sclerosis with natalizumab
  69. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
  70. Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?
  71. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide
  72. Charting the peptide crossreactome between HIV-1 and the human proteome
  73. No human protein is exempt from bacterial motifs, not even one
  74. Proposing Low-Similarity Peptide Vaccines againstMycobacterium tuberculosis
  75. Bacterial peptides are intensively present throughout the human proteome
  76. Proteome-guided search for influenza A B-cell epitopes
  77. Massive peptide sharing between viral and human proteomes
  78. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
  79. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes
  80. Sub-epitopic dissection of HCV E1315–328HRMAWDMMMNWSPT sequence by similarity analysis
  81. Peptidology: short amino acid modules in cell biology and immunology
  82. Identification of Monoclonal Anti-HMW-MAA Antibody Linear Peptide Epitope by Proteomic Database Mining
  83. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope
  84. Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients
  85. Clinical applications of DNA microarray analysis